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Abstract: The psychotherapeutic action of Li' in brain has 
been proposed to result from the depletion of cellular inosi- 
to1 secondary to its block of inositol monophosphatase. This 
action is thought to slow phosphoinositide resynthesis, 
thereby attenuating stimulated phosphoinositidase-me- 
diated signal transduction in affected cells. In the present 
study, the effect of Lit on muscarinic receptor-stimulated 
formation of the immediate precursor of phosphatidylinosi- 
tol, CDP-diacylglycerol (CDP-DAG), has been examined in 
human SK-N-SH neuroblastoma cells that have been cul- 
tured under conditions that alter the cellular content of 
myo-inositol. Resting neuroblastoma cells, like brain cells 
in vivo, were found to concentrate inositol from the culture 
medium, achieving an intracellular level of 60.0 k 4 nmol/ 
mg of protein. The addition of carbachol to [3H]cytidine- 
prelabeled cells elicited a four- to fivefold increase in the 
accumulation of labeled CDP-DAG. This stimulated for- 
mation of [3H]CDP-DAG was completely blocked by the 
addition of 10 pM atropine, was not dependent on the pres- 
ence of Li', nor was it affected by co-incubation with myo- 
inositol. This result was in sharp contrast to findings in rat 
brain slices, in which carbachol-stimulated formation of 
t3H]CDP-DAG was potentiated - 10-fold by Li' and sub- 
stantially reduced by coincubation with inositol. The for- 
mation of [3H]CDP-DAG in labeled SK-N-SH cells by car- 
bachol was both concentration and time dependent. The 
order of efficacy of muscarinic ligands in stimulating [3H]- 
CDP-DAG accumulation paralleled that established in 
these cells for inositol phosphate accumulation, i.e., carba- 
chol z oxotremorine-M 3 bethanecol2 arecoline > oxotre- 
morine > pilocarpine. Extended culture of the SK-N-SH 
cells in an inositol-free chemically defined growth medium 
progressively reduced the intracellular inositol content to 
4 nmol/mg of protein, a level comparable with that seen in 
cortical slices. In these inositol-depleted cells, Li' poten- 
tiated carbachol-stimulated [3H]CDP-DAG formation, and 
this effect was completely reversed by coincubation with 
inositol (ECS0 0.2 mM). The present study thus demon- 
strates, in the same cultured cell line, the effects of normal 
and reduced intracellular inositol levels on the ability of Li' 
to attenuate phosphoinositide resynthesis, as inferred from 
[3H]CDP-DAG accumulation. The results indicate that Li' 
can lead to a slowing of stimulated phosphoinositide turn- 
over in neuroblastoma cells, provided that the intracellular 
inositol content has been significantly reduced. Key Words: 
CDP-diacylglycerol-Inositol-Lithium-Muscarink- 
Neuroblastoma-Phosphoinositides. Stubbs E. B. Jr. and 
Agranoff B. W. Lithium enhances muscarinic receptor- 
stimulated CDP-diacylglycerol formation in inositol-de- 
pleted SK-N-SH neuroblastoma cells. J.  Neurochern. 60, 
1292-1299 (1993). 
Lithium (Li+) is widely used in the treatment of 
manic-depressive disorders, although the molecular 
basis of its therapeutic action remains unclear. The 
possibility of a postreceptor site of action was sug- 
gested from earlier studies reporting an inhibition of 
stimulated adenylate cyclase activity by Lif in several 
tissues, including brain (Forn and Valdecasas, 197 1 ; 
Ebstein et al., 1980). Attenuation of the phosphoino- 
sitidase-mediated signal transduction pathway by Lit, 
a potent uncompetitive inhibitor of inositol mono- 
phosphatase (Hallcher and Sherman, 1980), was sug- 
gested by a number of studies (Allison and Stewart, 
1971; Allison et a].., 1976; Sherman et al., 1981, 1985) 
that demonstrated a large accumulation of inositol 
monophosphates concomitant with a reduction in 
inositol content after CNS receptor activation. That 
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inhibition of inositol monophosphatase by Li+ may 
result in the depletion of intracellular inositol con- 
tent, and thereby interrupt the resynthesis of phos- 
phoinositides (Sherman et al., 1981; Berridge et al., 
1982), is particularly relevant to the CNS because ino- 
sitol cannot be readily replenished from the periphery 
due to the selective permeability of the blood-brain 
barrier. Recent studies using cerebral cortex slices 
have demonstrated inhibitory effects of Li+ on musca- 
r ink stimulated inositol tris- and tetrakisphosphate 
accumulation (Whitworth and Kendall, 1988; Ken- 
nedy et al., 1989, 1990), an effect that is shown in 
some cases to be reduced by coincubation with inosi- 
tol. However, the inability of Li+ to reduce levels 
of phosphatidylinositol 4,5 -bisphosphate (PIP, ) in 
treated tissue (Drummond and Raeburn, 1984; 
Downes and Stone, 1986; Honchar et al., 1989) com- 
plicates the inositol depletion model. A multiplicity of 
the effects of Li+ on several enzymes of the inositol 
phosphate cycle (Inhorn and Majerus, 1987; Gee et 
al., 1988) and alternate mechanisms including other 
postreceptor sites (Wood and Goodwin, 1987; God- 
frey et al., 1989; Avissar et al., 1988, 1991) are now 
recognized. 
More direct evidence for an effect of Li' on the 
phosphoinositidase-mediated second messenger sys- 
tem has been obtained by measuring agonist-induced 
formation of CDP-diacylglycerol (CDP-DAG), the 
immediate precursor of phosphatidylinositol (PI), in 
brain slices (Godfrey, 1989; Kennedy et al., 1990). 
Although this effect by Li' on CDP-DAG accumula- 
tion has also been observed in parotid gland slices 
(Downes and Stone, 1986), human platelets (Watson 
et al., 1990), and human neutrophils (Stubbs et al., 
1992), it could not be demonstrated in cultured cells 
(Drummond and Raeburn, 1984). The response to 
Li+ in these various cell preparations might be ex- 
plained on the basis of differences in endogenous ino- 
sitol levels. The present study was therefore under- 
taken to examine the effect of Lif on muscarinic ago- 
nist stimulation of CDP-DAG in cultured human 
SK-N-SH neuroblastoma cells grown under condi- 
tions that modulate intracellular inositol content. A 
preliminary report of this study has appeared in ab- 
stract form (Stubbs et al., 1991). 
MATERIALS AND METHODS 
Human SK-N-SH neuroblastoma cells of the neuroblast 
phenotype were cultured at 37°C in a humidified atmo- 
sphere (10% C0,/90% air) in Dulbecco's modified Eagle's 
medium supplemented with 10% fetal bovine serum 
(GIBCO BRL, Grand Island, NY, U.S.A.). Where specified, 
SK-N-SH cells were cultured in an inositol-free chemically 
defined (IFCD) growth medium (Bottenstein and Sato, 
1979), which was changed daily for 5-7 days for the purpose 
of depleting cellular inositol. Adolescent (1 3- 18 days) rats 
were killed by decapitation and the cerebral cortex was dis- 
sected, cross-chopped with a Mcllwain tissue chopper (350 
X 350 pm), and slices were washed as described previously 
(Heacock et al., 1987). SK-N-SH cells grown to confluency 
(7-10 days) were harvested with Puck's D, solution, washed 
once with buffer A containing (M) NaCl 142, KC1 5.4, 
NaHCO, 3.6, CaCI, 2.2, MgCI, 1.0, Dglucose 5.6, and 
HEPES 30, pH 7.4, saturated with OJCO, (19:1, vol/vol), 
and suspended at a concentration of 1-2 mg of protein/ml. 
Gravity-packed slices (50 pl) or suspended cells (-0.3 mg of 
protein), in a final volume of 500 pl, were incubated in 
flat-bottomed polypropylene minivials in the presence of 
[3H]cytidine (specific activity 25 Ci/mmol, 3 pCi per mini- 
vial; Sigma Chemical Co., St. Louis, MO, U.S.A.) for 60 
rnin at 37°C followed by stimulation with either buffer A or 
a muscarinic agonist for 30-60 min. Reactions were 
quenched by the addition of 1.5 ml of chloroform/methanol 
(1:2, vol/vol), and labeled lipids were extracted from the 
lower phase formed upon the addition of 0.5 ml of HCl(l.2 
M )  and 1.0 ml of chloroform. After phase separation by 
low-speed centrifugation, a portion of the resultant lower 
phase was washed twice with acidified methanol containing 
2.5 mMcytidine (Sigma) and [3H]CDP-DAG was identified 
by TLC on oxalate-impregnated silica gel 60 plates devel- 
oped in chloroform/acetone/methanol/acetic acid/water 
(40: 15: 13: 1223, by vol). The radiolabeled band comigrating 
with authentic CDP-DAG standard (see Fig. I )  was scraped 
and counted. Alternatively, a fraction of the acid-washed 
organic phase was dried and counted by scintillation spec- 
trometry. 
Cellular inositol was quantitated by a modification of the 
acetylation method of Mount and Laker (198 1). In brief, 
prepared cells or cortical slices (- 1 mg of protein each) 
were suspended in a total volume of 1 ml with distilled 
water in the presence of 50 pg of xylitol internal standard 
(Sigma). Cells or tissue slices were disrupted with 1.5 ml of 
chloroform/methanol (12, vol/vol) and were vortexed vig- 
orously, followed by the addition of I .O ml of chloroform. 
After phase separation by low-speed centrifugation, the up- 
per aqueous phase was dried overnight in vacuo and then 
stored for at least 1 h over phosphorus pentoxide. Samples 
were acetylated by incubating at 70°C for 30 rnin in 0.5 ml 
of pyridine (previously refluxed for 30 rnin over potassium 
hydroxide and redistilled) followed by the addition of0.5 ml 
of acetic anhydride for an additional 10 rnin at 70°C. Acety- 
lated samples were dried and stored as described above be- 
fore separation on an SP2330 capillary column (Supelco, 
Bellefonte, PA, U.S.A.) using a Hewlett Packard 5890A gas 
chromatograph programmed with an isothermal oven tem- 
perature at 200°C for the first 2 rnin followed by a linear 
ramp up to 250"C, rising at a rate of 4"C/min, and sus- 
tained for an additional I4 min. Peaks were quantitated 
with a Hewlett Packard 3396A integrator. Under these con- 
ditions, acetylated inositol chromatographed free of glucose 
anomers and eluted as a single peak with a retention time of 
23.5 min. 
RESULTS 
Muscarinic receptor-stimulated formation of rH]- 
CDP-DAG 
The addition of carbachol (10 miM) to [3H]- 
cytidine-prelabeled SK-N-SH neuroblastoma cells re- 
sulted in a three- to fivefold increase of a single 'H- 
lipid-soluble substance that, when separated by TLC 
(Fig. 1 ), comigrated with authentic CDP-dipalmitin 
and with CDP-DAG prepared from egg lecithin (R, 
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FIG. 1. Autoradiogram of [3H]cytidine-labeled lipids extracted 
from SK-N-SH neuroblastorna. Cells (0.4 mg of protein) were pre- 
labeled with rH]cytidine (6 pCi/rnl) for 60 min at 37°C and subse- 
quently treated with buffer A (control; Con), 10 mM carbachol 
(CCh), 10 rnM carbachol + 10 pM atropine (CCh f Atr), or 10 mM 
carbachol + 10 mM inositol (CCh + Inos), as indicated, for an 
additional 30 min. Lipids were extracted and separated as de- 
scribed in Materials and Methods. 0, origin; Sf, solvent front. 
= 0.43). A qualitatively similar autoradiographic pro- 
file was observed when [3H]cytidine-prelabeled corti- 
cal slices were stimulated with 1 mM carbachol (data 
not shown). As has been previously observed, carba- 
chol or Li+ alone had no effect on CDP-DAG accu- 
mulation, whereas the combination produced pro- 
nounced enhancement (Godfrey, 1989). In contrast 
to results from experiments with cortical slices, the 
stimulated formation of [3H]CDP-DAG in cultured 
cells was independent of Li+ and was found to be in- 
sensitive to the presence of inositol (Table 1). This 
stimulated production of [ 3H]CDP-DAG in SK-N- 
SH cells was time and concentration dependent. 
There was a fivefold increase in [3H]CDP-DAG accu- 
mulation, which reached asymptote within 10 rnin of 
carbachol addition and was sustained for at least 30 
min (Fig. 2). In parallel incubations, the addition of 
10 pM atropine to carbachol-stimulated cells caused a 
rapid depletion of [3H]CDP-DAG, suggesting metabo- 
lism of newly synthesized CDP-DAG subsequent to 
muscarinic receptor blockade. The Lit-independent 
formation of [3H]CDP-DAG was observed at carba- 
chol concentrations as low as 1 pMand was maximal 
at 1 m M  with a half-maximal accumulation at 7.5 
k 0.5 pM (Fig. 3). The selectivity of muscarinic ago- 
nists in stimulating [3H]CDP-DAG formation agreed 
well with the known efficacy of these agents in initiat- 
ing phosphoinositide turnover in SK-N-SH cells 
(Fisher and Snider, 1987). In three separate experi- 
ments, the full muscarinic agonist oxotremorine-M ( 1 
mM) was as effective at eliciting [3H]CDP-DAG for- 
mation (90 f 6%) as 1 mM carbachol, whereas equi- 
molar concentrations of partial muscarinic agonists 
were less effective; thus, bethanechol(74 * 3%) = are- 
coline (73 * 4%) > oxotremorine (63 & 1%) > pilocar- 
pine (44 f 3%). 
Intracellular inositol content 
The inositol content of freshly cut cortical slices of 
adolescent rat brain was found to be 21 k 0.9 nmol/ 
mg of protein (n = 6) ,  the same as is found in cortical 
samples taken directly from the brain shortly after 
decapitation (2 1.1 f 1.7 nmol/mg of protein; n = 3). 
After the washing procedure, the inositol content of 
the slices was reduced to 8.9 f 0.4 nmol/mg of protein 
(n = 6, p < 0.001), or -0.9 mM, well below the re- 
ported K, (4.6 mMinosito1) for rat brain PI synthase 
(Ghalayini and Eichberg, 1985). This 60% reduction 
in cellular inositol content may thus slow PI synthase 
on the basis of substrate limitation, resulting in the 
accumulation of lipid precursors of the phosphoinosi- 
tide cycle such as DAG, DAG-phosphate (phosphati- 
date), and/or CDP-DAG. In contrast to cortical slices, 
the inositol content in washed SK-N-SH cells was 
found to be 60.0 +. 4.0 nmol/mg of protein (n = 8). 
This more closely approximates the value we found in 
the adult rat cortex, 48.5 f 1.5 nmol/mg of protein (n 
= 6 ) ,  a notably higher value than we observed in ado- 
lescent rat brain. These data suggest that the stimu- 
lated formation of [3H]CDP-DAG in SK-N-SH cells 
cultured in standard growth medium does not result 
from a deficit of cellular inositol, in contrast to what 
may well be the case in studies with prewashed corti- 
cal brain slices incubated in the presence of Li+ (God- 
frey, 1989; Kennedy et al., 1990; Table 1). 
TABLE I .  The efl& of LiCl and myo-inositol on I”H]CDP..DAG.f~rmution 
in human SK-N-SH neuroblastoma cells and cerebral cortex slices 
SK-N-SH Cortical slices 
Basal Carbachol Basal Carbachol 
Control 314 f 47 1,624 f 82 6,890 6,150 
LiCl 307 f 60 1,748 e 48 6,908 f 475 68,700 f 3,23 1 
LiCl + inositol 278 f 51 1,533 * 45 1,755 +- 88 11,660 f 1,662 
[3H]Cytidine-prelabeled cells (0.3-0.35 mg of protein) or 13-1 8-day-old-rat cortical slices ( 1  
mg of protein) were treated with buffer (control) and 10 mM LiCl with or without 10 mM 
inositol as indicated, followed by incubation with carbachol for an additional 30 rnin (cells) or 
60 rnin (slices). Data shown (dpm) are the means k SEM for separate SK-N-SH cell (n = 3) and 
cortical slice (n = 5 )  preparations. Control values for cortical slices are the average of duplicates. 
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FIG. 2. Time-dependent, atropine reversible, accumulation of 
[3H]CDP-DAG in carbachol-stimulated SK-N-SH neuroblastoma 
cells. [3H]Cytidine-prelabeled cells (0.35 mg of protein) were 
treated with buffer (open circles) or 10 mM carbachol (closed cir- 
cles) for the duration of time indicated. Parallel incubations re- 
ceived 10 pM atropine (arrow) 10 min after the addition of carba- 
chol (triangles). Data shown are the means f SEM from three 
experiments each performed in duplicate. See also Fig. 8. 
Potentiation by Li+ of stimulated 13H]CDP-DAG 
formation and reversal with inositol 
Treatment of SK-N-SH cells with 10 mM LiCl in 
culture for 48 h did not affect the intracellular content 
of inositol. At longer times in culture, indications of 
cellular toxicity became manifest. However, when 
SK-N-SH cells were cultured in an IFCD growth me- 
dium, a time-dependent reduction ofintracellular ino- 
sitol was observed (Fig. 4), without detectable effects 
on cell viability, as determined by trypan blue dye 
exclusion. By day 5, cellular inositol content was re- 
duced by >90%, to 5.5 k 0.5 nmol/mg of protein (n 
= 5). Cells appeared viable for longer time periods, 
but further reductions in cellular inositol were not 
seen. Prestimulation of IFCD-cultured SK-N-SH cells 
with 1 mMcarbacho1 for 120 min in the presence of 1 
mM LiCl further reduced the intracellular content of 
m - 3 1  
E *{  
9 
d " 1  
0 4  . ~ . .... 1 . I 7- . . 
10 10 10 10 
4 - 5 4  -3 2 
[CarbachoU M 
FIG. 3. Concentration-dependent stimulation of [3H]CDP-DAG 
formation by carbachol in SK-N-SH cells. [3H]Cytidine-prelabeled 
cells (0.35 mg of protein) were treated with the indicated concen- 
trations of carbachol for 30 min at 37°C. [3H]CDP-DAG was ex- 
tracted and quantitated as described in the legend of Fig. 1. The 
data shown are the means from three experiments, variance 
t5%. An EC5, of 7.5 f 0.5 FM was determined from probit analy- 
sis of the data. 
a 
0 1 2 3 4 5 
Time (days) 
FIG. 4. Time-dependent reduction of myo-inositol content in SK- 
N-SH neuroblastoma cells. Log-phase cells were cultured in an 
IFCD growth medium as described in the text for the number of 
days indicated and analyzed for inositol content as described in 
Materials and Methods. Data shown are the means ? SD of qua- 
druplicate determinations from a single experiment. 
inositol to <1 nmol/mg of protein. A comparison of 
the effect of Li+ on carbachol-stimulated [3H]CDP- 
DAG formation in IFCD-cultured cells before and 
after agonist pretreatment is shown in Fig. 5. It can be 
seen that basal accumulation of [3H]CDP-DAG is ele- 
vated in IFCD cells, reflecting a slowing of PI synthe- 
sis. When assayed in the absence of Li+, carbachol 
stimulated a small (52%), but significant, increase in 
[3H]CDP-DAG formation (Fig. 5A). Inclusion of 1 
mM Li+ to the incubation assay resulted in a greater 
than twofold increase in the stimulated formation of 
[3H]CDP-DAG (Fig. 5B). Prior treatment of IFCD- 
cultured cells with carbachol + LiCl ( 1 mM each) re- 
sulted in a maximal fourfold increase in subsequent 
carbachol-stimulated [3H]CDP-DAG formation (Fig. 
5C). In each case, coincubation with inositol(l0 M) 
completely reversed the stimulated formation of [3H]- 
CDP-DAG (Fig. 5) ,  suggesting that under these condi- 
tions, the accumulation of CDP-DAG resulted from 
inositol-substrate limitation of PI synthase and that 
therapeutic concentrations of Li+ further exacerbated 
this limitation. This effect by Lit on [3H]CDP-DAG 
formation was maximally effective at 10 mM with an 
EC,, of 2.6 f 0.3 mM (Fig. 6). At concentrations as 
low as 50 pM, inositol reduced this potentiation by 
Li+, was maximal at 10 mM, and exhibited a half- 
maximal effect at 0.20 * 0.03 mM (Fig. 7). 
To further investigate the nature of the atropine 
effect on [3H]CDP-DAG accumulation, the experi- 
ment described in Fig. 2 was repeated in inositol-de- 
pleted cells. Under these conditions, a linear accumu- 
lation of [3H]CDP-DAG was seen after addition of 
carbachol for 15 min, which then increased at later 
times. Atropine addition again resulted in a loss of 
labeled liponucleotide (Fig. 8). 
DISCUSSION 
It has been amply demonstrated that after preincu- 
bation with [3H]inositol, the addition of an appro- 
priate ligand such as carbachol in the presence of Li+ 
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FIG. 5. Stimulated accumulation of [3H]CDP-DAG by carbachol in inositol-deficient SK-N-SH cells: potentiation by Lit and reversal with 
myo-inositol. Cells were cultured for 6-7 days in an IFCD growth medium and prestimulated with buffer (A, B) or 1 mM carbachol/l mM 
LiCl (C) for 2-4 h before harvest. Harvested cells (0.3 mg of protein) were then prelabeled for 60 min with [%]cytidine in the absence (A) or 
presence (B, C) of 1 mM LiCl and stimulated for an additional 30 min with either buffer (control), 1 mM carbachol (CCh), or 1 mM carbachol 
in the presence of 10 mM inositol (CCh + Inositol), as indicated. Data shown are the means f SEM from three to five experiments. The 
cellular content of inositol before prestimulation was 7 nmol/mg of protein. Prestimulation with carbachol in the presence of Li+ further 
reduced the cellular content of inositol below detectable levels (4 nmol/mg of protein). 
to a tissue slice or cultured cell incubation medium 
results in a pronounced accumulation oflabeled inosi- 
to1 phosphates (see Fisher et al., 1992). Although it is 
evident that this accumulation is attributable to the 
uncompetitive inhibition of inositol monophospha- 
tase by Li+ (Hallcher and Sherman, 1980), it is less 
clear that this action of Li+ can also explain its well- 
known beneficial actions in the treatment of psy- 
choses. The inositol depletion hypothesis for the psy- 
chotherapeutic action of Li+ proposes that the block 
of inositol monophosphatase creates a shortage of ino- 
sitol as substrate for the regeneration of phosphoinosi- 
tides via PI synthase, and that this effect of Li+ is espe- 
cially profound in those cells that have been most 
heavily stimulated (Bemdge et al., 1982). Reversal by 
inositol of a Li+-mediated decrease of inositol poly- 
phosphates in tissue slices (Whitworth and Kendall, 
1988; Kennedy et al., 1989, 1990) appears to support 
0.1 1 10 100 
ILiCll mM 
FIG. 6. Concentration-dependent accumulation of [3H]CDP-DAG 
by Li+ in carbachol-stimulated inositol-deficient SK-N-SH cells. 
Cells (0.3 mg of protein), previously cultured for 7 days in an IFCD 
growth medium, were prelabeled with [3H]cytidine for 50 min, 
treated with the indicated concentration of LiCl for an additional 
10 min, and stimulated with 1 mM carbachol (closed circles) or 
buffer (open circles) for an additional 30 min. The inositol content 
of conditioned cells was 3 nmol/mg of protein. Data shown are 
the means k SEM from three cell preparations. Variance was less 
than symbol size where error bars are absent. 
the hypothesis. Further support comes from recent in 
vivo evidence (Sun et al., 1992) that Li+ increases ino- 
sitol phosphates, based on chemical mass determina- 
tions and labeled inositol incorporation. On the other 
hand, Whitworth et al. (1990) suggested that both 
chronic and acute Li+ treatment in vivo may actually 
enhance stimulated phosphoinositide turnover in 
brain. Sillence and Downes ( 1992) recently reported 
that both chemical amounts and labeling of the inosi- 
to1 phosphates were increased in Li+-treated tissue 
slices, but that increases seen in inositol phosphate 
mass were much less than labeling might otherwise 
indicate. 
A major concern regarding the relevance of the ino- 
sitol depletion hypothesis for the nervous system is 
the high content of inositol in the brain, and the rela- 
tively small decreases that are produced by chronic, or 
even by high acute doses of Lif in experimental ani- 
CI 0.1 1 10 
[Inositol] mM 
FIG. 7. Reversal of carbachol-stimulated [3H]CDP-DAG accumu- 
lation by myo-inositol in conditioned SK-N-SH cells. Cells (0.3 mg 
of protein), previously cultured for 8 days in an IFCD growth me- 
dium, were prelabeled with [3H]cytidine for 50 min in the presence 
of 1 mM LiCI, treated with the indicated concentrations of inositol 
for an additional 10 min, and stimulated with carbachol(1 mu) for 
an additional 30 min. The inositol content of conditioned cells was 
6 nmol/mg of protein. Data shown are the means k SEM from 
three cell preparations. 
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FIG. 8. Time-dependent, atropine-reversible, accumulation of 
[3H]CDP-DAG in carbachol-stimulated inositol-deficient SK-N-SH 
neuroblastoma cells. Cells (0.4 mg of protein), previously cultured 
for 8 days in an IFCD growth medium, were prelabeled with f’H]- 
cytidine for 60 min in the presence of 10 mM LiCl and then treated 
with buffer (open circles) or 10 mM carbachol (closed circles) for 
the duration of time indicated. Parallel incubations received 10 pM 
atropine (arrow) 10 min after the addition of carbachol (triangles). 
Data shown are the means from three experiments each per- 
formed in duplicate, variance <lo%. Inset: Comparison of carba- 
chol-stimulated [3H]CDP-DAG formation in cells cultured in media 
containing inositol (open circles, data from Fig. 2)  or IFCD media 
(this experiment; closed circles). 
mals. Proponents of the inositol depletion hypothesis 
must then further postulate either that inositol has 
become depleted in an unmeasured, but behaviorally 
relevant, brain compartment (for example in neu- 
rons), or alternatively that there exists a PI synthase 
isozyme that has a higher K, for inositol than has thus 
far been demonstrated, but this has not as yet been 
found (Imai and Gershengorn, 1987). 
The experimental approach used in the present 
study is based on the assumption that a slowing of the 
phosphoinositide cycle secondary to inositol deple- 
tion will result in an accumulation of CDP-DAG, the 
cosubstrate, with inositol, for PI synthase. Li+ pro- 
duced no demonstrable effect on stimulated [3H]- 
CDP-DAG accumulation in SK-N-SH cells grown in 
standard culture media. Drummond and Raeburn 
( 1984) had similarly reported an insensitivity of cul- 
tured GH, pituitary cells to Li+ in regard to ligand- 
stimulated accumulation of labeled CDP-DAG. 
When we reduced cellular inositol levels in the neuro- 
blastoma cells to the range of that seen in washed 
brain slices, the cultured cells now showed an inositol- 
sensitive, Li+-stimulated enhancement of muscarinic 
receptor-stimulated accumulation of [3H]CDP- 
DAG. It is thus possible to manipulate cellular inosi- 
to1 as an experimental variable. The results indicate a 
selective effect of Li’ on inositol-deficient tissues. In 
the case of brain slices, this is a consequence of wash- 
ing in inositol-free buffer, whereas in the case of cul- 
tured cells, it is accomplished by growth on inositol- 
free media. It appears that much of the variation seen 
in different experimental preparations for the study of 
brain Li+ effects can be explained on the basis of dif- 
ferences in inositol content. Adult rat brain inositol 
content is 3-5 mM (Sherman et al., 1985), and 60- 
80% of this is lost in brain slice preparation as re- 
ported by Sherman et al. (1 986), which is confirmed 
in the present study. SK-N-SH neuroblastoma cells 
have comparably high inositol levels, but unlike brain 
slices, retain their inositol even after extensive wash- 
ing in inositol-free buffer. The ability to concentrate 
and/or retain inositol in various cell lines has not been 
studied systematically, although it has been reported 
that C6 glioma cells maintain a higher intracellular/ 
extracellular inositol gradient than N 1 E- 1 15 neuro- 
blastoma cells (Glanville et al., 1989). The lowest lev- 
els of cellular inositol encountered in this study were 
in inositol-deprived cells that were also carbachol 
stimulated. The observation could be taken as sup- 
port for the existence of low inositol levels in stimu- 
lated cells that then become subject to the Li+-me- 
diated slowing of phosphoinositide turnover, as is 
proposed in the inositol-depletion hypothesis. It is 
also of interest that even when inositol is not available 
to SK-N-SH cells, they exhibit relatively normal 
growth rates. This may indicate the presence of some 
activity of inositol 3-phosphate synthase. This en- 
zyme, which cyclizes glucose 6-phosphate, is thought 
to reside primarily in the brain capillary endothelium 
(Wong et al., 1987). 
The observed Lif-independent, muscannic stimula- 
tion of [3H]CDP-DAG formation in neuroblastoma 
cells grown in standard growth media is interpreted to 
indicate that the PI synthase of these cells is normally 
saturated with regard to inositol and is operating near 
its V,,,. This interpretation would also explain the 
observed ineffectiveness of added inositol in reversing 
the [3H]CDP-DAG accumulation. Alternatively, the 
observed stimulatory effect of the addition of carba- 
chol alone on [3H]CDP-DAG accumulation in cells 
that had not been depleted of their inositol could indi- 
cate the presence of a “low inositol” intracellular 
compartment together with PI synthase. Such an ex- 
planation has been suggested as a result of kinetic stud- 
ies of CDP-DAG accumulation in sciatic nerve (Zhu 
and Eichberg, 1990). This possibility appears unlikely 
in the present study because coincubation of SK-N- 
SH cells with I0 mMinosito1 did not block the stimu- 
lated accumulation of [3H]CDP-DAG. 
The plateau of [3H]CDP-DAG seen after musca- 
rinic receptor activation in cells cultured in inositol- 
containing media is interpreted to indicate the devel- 
opment under these conditions of a steady state in 
which the rate of synthesis of the liponucleotide ap- 
proaches its rate of degradation. The subsequent re- 
ceptor blockade by atropine then leads to reduced 
PIP, breakdown, and thereby limits the availability of 
(stearoyl arachidonoyl) DAG for PI resynthesis. 
When the metabolic fate of CDP-DAG was further 
investigated in inositol-depleted cells, an increased 
rate of labeled liponucleotide formation was ob- 
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served, particularly at later incubation times. This in- 
creased rate suggests a slowing of PI synthase second- 
ary to a reduction in available inositol. The late in- 
crease then likely reflects further depletion of 
available inositol and arrest of PI synthase activity. 
Under these conditions, the loss of [3H]CDP-DAG 
seen upon addition of atropine is indicative of ongo- 
ing metabolism of CDP-DAG other than via PI syn- 
thase. For example, the liponucleotide could be me- 
tabolized to phosphatidate, either by reversal of the 
CDP-DAG synthase reaction or by pyrophosphoroly- 
sis (Murthy and Agranoff, 1982). Because CDP-DAG 
may be a limiting substrate in the phosphoinositide 
cycle, CDP-DAG pyrophosphatase could well serve a 
regulatory function. Still another possibility, the con- 
version of CDP-DAG to the phosphatidylglycerolip- 
ids appears improbable because these mitochondria1 
structural lipids turn over relatively slowly. 
It is clear from the present study that varying the 
cellular inositol concentration can drastically alter the 
observed biochemical effects of Li', and further, that 
the inositol content of cultured cells is more represen- 
tative of intact rat brain than is that of washed rat 
brain slices. Because SK-N-SH cells do not survive in 
millimolar Li+-containing media for long periods of 
time, we could not explore the possible effects of Li+ 
that can be elicited only after several days of in vivo 
exposure. Although we observed no significant inosi- 
to1 decrease in cultured cells exposed briefly to Li+, it 
remains possible that exposure of the intact brain to a 
combination of chronic Li+ and a sustained excess of 
phosphoinositide-linked ligands (perhaps in specific 
brain regions) leads to the inositol depletion that has 
been hypothesized to mediate the psychotherapeutic 
effect of Li+. The present study nevertheless under- 
scores potential hazards in simple extrapolation of in 
vitro results, on the one hand, and oversimplification 
of mechanism, on the other, to explain the in vivo 
effects of Li+. 
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